Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-Nitrosylation Therapy During Autologous Blood Transfusion
NCT03999229Phase 1Recruiting
- Start
- Jul 2019
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of ethyl nitrite in transfusion reaction (2 arms). Primary endpoints: Peripheral Tissue Oxygenation at 24 hours and Oxygen Utilization at 24 hours. Started Jul 2019; status: recruiting.
02
Drugs
ethyl nitrite
03
Conditions
transfusion reaction
Beyond the preview
Go deeper on NCT03999229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03999229.